OTR Acquisition Corp. (OTRA) to Combine with Comera Life Sciences in $151M Deal

OTR (NASDAQ:OTRA) has entered into a definitive agreement to combine with biotech firm Comera Life Sciences at an enterprise value of $151.3 million. The Woburn, Massachusetts-based company utilizes formulation science and technology to transform essential biologic medicine from IV to subcutaneous forms. The combined company is expected to trade on the Nasdaq once the deal
Read More